Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 25,733 |
|
|||||
| News | - | ||||||
| Day High | 4.28 | Low High |
|||||
| Day Low | 3.91 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Prelude Therapeutics Inc | PRLD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.05 | 1.24% | 4.09 | 00:00:02 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.05 | 3.91 | 4.28 | 4.09 | 4.04 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 430 | 25,733 | $ 4.02 | $ 103,468 | - | 1.66 - 6.09 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:02:19 | priorref | 378 | $ 4.09 | USD |
Prelude Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 224.08M | 54.92M | - | 0 | -121.83M | -2.22 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Prelude Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRLD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.29 | 4.42 | 3.86 | 4.06 | 30,387 | -0.20 | -4.66% |
| 1 Month | 4.04 | 4.42 | 3.56 | 3.93 | 33,085 | 0.05 | 1.24% |
| 3 Months | 4.29 | 5.83 | 3.42 | 4.35 | 42,511 | -0.20 | -4.66% |
| 6 Months | 3.41 | 5.83 | 2.62 | 3.71 | 98,150 | 0.68 | 19.94% |
| 1 Year | 5.39 | 6.09 | 1.66 | 3.57 | 118,489 | -1.30 | -24.12% |
| 3 Years | 39.10 | 43.5499 | 1.66 | 12.85 | 185,082 | -35.01 | -89.54% |
| 5 Years | 25.76 | 95.375 | 1.66 | 20.67 | 189,041 | -21.67 | -84.12% |
Prelude Therapeutics Description
| Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need. |
